Vestibular suppressant drugs.
D000925:Anticoagulants / Q000627:therapeutic use; D000932:Antiemetics / Q000627:therapeutic use; D001639:Bicarbonates / Q000627:therapeutic use; D002245:Carbon Dioxide / Q000627:therapeutic use; D003911:Dextrans / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D005419:Flavonoids / Q000627:therapeutic use; D006632:Histamine / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D012138:Respiratory Therapy; D014149:Tranquilizing Agents / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use; D014717:Vertigo / Q000188:drug therapy*; D014725:Vestibular Nerve / Q000187:drug effects*; D014722:Vestibule, Labyrinth / Q000187:drug effects
D000925:Anticoagulants; D000932:Antiemetics; D001639:Bicarbonates; D003911:Dextrans; D004232:Diuretics; D005419:Flavonoids; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D010276:Parasympatholytics; D014149:Tranquilizing Agents; D014665:Vasodilator Agents; D002245:Carbon Dioxide; D006632:Histamine